← 홈

HER2+ 유방암

426개 · ADC 1068 · Antibody 5456 · CGT 2744 · 다음 갱신 D-13 · 마지막 7월 13일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 426개
AntibodystaleRochePhase 2

trastuzumab (Herceptin, Trastuzumab+Pertuzumab/Trastuzumab)

Breast Cancer; Adjuvant Therapy · Breast Cancer

#BreastCancer#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 RECRUITING
AntibodystaleRochePhase 2

trastuzumab (Herceptin, Trastuzumab+pyrotinib+taxene)

Breast Cancer · Breast Cancer

#BreastCancer#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleRochePhase 2

trastuzumab (Herceptin, Trastuzumab, Pertuzumab, Paclitaxel, or a combination of these drugs)

Metastatic Breast Cancer; HER2-positive Breast Cancer · HER2

#HER2#Antibody#Phase2#항체#면역항체+4
임상시험 1상태 RECRUITING
AntibodystaleRochePreclinical

trastuzumab (Herceptin, Trastuzumab-rezetecan Treatment Group)

Trastuzumab-rezetecan; HER2-low Breast Cancer · HER2

#HER2#Antibody#Preclinical#항체#면역항체+4
임상시험 1상태 RECRUITING
AntibodystaleAstraZenecaPhase 2

Tremelimumab monotherapy (Tremelimumab monotherapy)

Urothelial Bladder Cancer; Triple-negative Breast Cancer · Urothelial Bladder Cancer

#UrothelialBladderCancer#Antibody#Phase2#항체#면역항체+3
효능 ORR 3.1%임상시험 1상태 ACTIVE
AntibodystaleQuantumLeap Healthcare Collabor…Phase 2

trastuzumab (Herceptin, Trilaciclib with or without trastuzumab + pertuzumab)

Breast Neoplasms; Breast Cancer · HER2

#HER2#Antibody#Phase2#항체#면역항체+4
임상시험 1상태 RECRUITING
ADCBiologicstaleFondazione per la Medicina Pers…Phase 2

Vismogedib (Vismogedib)

Breast Cancer; Gastrointestinal Cancer · Breast Cancer

#BreastCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
임상시험 1상태 ACTIVE
ADCBiologicstaleMersana TherapeuticsPhase 1

XMT-1522 (XMT-1522)

Advanced Breast Cancer; Advanced Nonsmall Cell Lung Cancer · Advanced Breast Cancer

#AdvancedBreastCancer#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+2
임상시험 1상태 ACTIVE
ADCBiologicstaleMediLink Therapeutics (Suzhou) …Phase 2

YL202 should be intravenously infused (YL202 should be intravenously infused)

NSCLC; Breast Cancer · NSCLC

#NSCLC#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
임상시험 1상태 RECRUITING
AntibodystaleHoffmann-La RochePhase 2

trastuzumab (Herceptin, ZN-A-1041 + PHESGO / Herceptin plus Perjeta injection for Phase 1b)

Advanced Solid Tumors; HER2-positive Breast Cancer · HER2

#HER2#Antibody#Phase2#항체#면역항체+4
임상시험 1상태 RECRUITING
AntibodystaleHoffmann-La RochePhase 2

trastuzumab (Herceptin, ZN-A-1041 + PHESGO / Herceptin plus Perjeta injection for Phase 1c)

Advanced Solid Tumors; HER2-positive Breast Cancer · HER2

#HER2#Antibody#Phase2#항체#면역항체+4
임상시험 1상태 RECRUITING
AntibodystaleMerus B.V.Phase 2

Zenocutuzumab (Zenocutuzumab)

Breast Cancer Metastatic · Breast Cancer Metastatic

#BreastCancerMetastatic#Antibody#Phase2#항체#면역항체+2
효능 ORR 0%임상시험 1상태 ACTIVE
AntibodystaleRochePhase 2

bevacizumab combined with dose dense chemotherapy (bevacizumab combined with dose dense chemotherapy)

Breast Cancer · Breast Cancer

#BreastCancer#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE
ADCBiologicstaleMabwell (Shanghai) Bioscience C…Phase 1

bulumtatug fuvedotin (bulumtatug fuvedotin)

Triple Negative Breast Cancer · Triple Negative Breast Cancer

#TripleNegativeBreastCancer#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+1
임상시험 1상태 RECRUITING
CGTBiologicstaleUniversity of PennsylvaniaPhase 1

cMet RNA CAR T cells (cMet RNA CAR T cells)

Metastatic Breast Cancer; Triple Negative Breast Cancer · Metastatic Breast Cancer

#MetastaticBreastCancer#CGT#Phase1#세포유전치료#CAR-T+3
임상시험 1상태 ACTIVE
AntibodystaleRochePhase 2

trastuzumab (Herceptin, capecitabine and trastuzumab)

Breast Cancer · Breast Cancer

#BreastCancer#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 RECRUITING
AntibodystaleRochePhase 2

trastuzumab (Herceptin, carboplatin and paclitaxel and or without trastuzumab)

Breast Cancer · Breast Cancer

#BreastCancer#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleThe Netherlands Cancer InstitutePhase 1

atezolizumab (Tecentriq, carbplatin, cyclophophamide, atezolizumab)

Breast Cancer; Cervix Cancer · Breast Cancer

#BreastCancer#Antibody#Phase1#항체#면역항체+3
임상시험 1상태 ACTIVE
AntibodystaleGBG Forschungs GmbHPhase 3

epirubicin - cyclophosphamide / docetaxel + bevacizumab (epirubicin - cyclophosphamide / docetaxel + bevacizumab)

Breast Cancer · Breast Cancer

#BreastCancer#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleGBG Forschungs GmbHPhase 3

trastuzumab (Herceptin, epirubicin - cyclophosphamide / docetaxel + trastuzumab)

Breast Cancer · Breast Cancer

#BreastCancer#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 ACTIVE

20 / 22 페이지

← 이전다음 →